Sub-$1 Watch: 10 Stocks That Could Explode — October 12, 2026

Introduction In the world of penny stocks, opportunities for explosive growth exist alongside significant risks. This article delves into ten stocks trading under $1 that show potential for rapid price appreciation. Each stock is evaluated based on volume profiles, short interest, catalysts, technical setups, and risk factors.

1. SNDL - Sundial Growers Inc. - **Current Price:** $0.39 - **Sector:** Cannabis - **Volume Profile:** Increasing volume suggests accumulation. - **Short Interest:** High short interest at 25% indicates potential for a short squeeze. - **Catalyst:** Anticipation of cannabis legalization reforms in the U.S. - **Technical Setup:** Recently bounced off support around $0.35. - **Risk Factors:** Regulatory changes could negatively impact operations. - **Bull Case Price Target:** $0.75 (30-90 days) - **Risk Rating:** 🔴 Very High

2. MVIS - Microvision, Inc. - **Current Price:** $0.73 - **Sector:** Technology - **Volume Profile:** Recent spikes in volume indicate strong interest. - **Short Interest:** Approximately 30% short interest points to squeeze potential. - **Catalyst:** Potential contract with major automotive manufacturers for lidar technology. - **Technical Setup:** Experiencing a breakout from a prolonged consolidation period. - **Risk Factors:** Dependence on large contracts; competition is fierce. - **Bull Case Price Target:** $1.20 (30-90 days) - **Risk Rating:** 🔴 Very High

3. CLOV - Clover Health Investments Corp. - **Current Price:** $0.88 - **Sector:** Healthcare - **Volume Profile:** Noticeable increase in trading volume suggests accumulation. - **Short Interest:** High short interest at 22% indicates potential for a squeeze. - **Catalyst:** Upcoming earnings report could exceed market expectations. - **Technical Setup:** Currently testing resistance around $0.90. - **Risk Factors:** Regulatory scrutiny and operational challenges. - **Bull Case Price Target:** $1.50 (30-90 days) - **Risk Rating:** 🔴 Very High

4. GCT - GCT Semiconductor, Inc. - **Current Price:** $0.55 - **Sector:** Semiconductor - **Volume Profile:** Significant volume increase suggests bullish sentiment. - **Short Interest:** 18% short interest indicates potential for upward momentum. - **Catalyst:** New product launches could drive revenue growth. - **Technical Setup:** Bouncing off support at $0.50. - **Risk Factors:** Market volatility and supply chain disruptions. - **Bull Case Price Target:** $0.85 (30-90 days) - **Risk Rating:** 🟡 High

5. BLNK - Blink Charging Co. - **Current Price:** $0.95 - **Sector:** Renewable Energy - **Volume Profile:** Increasing volume suggests strong interest. - **Short Interest:** 15% short interest may indicate potential for a squeeze. - **Catalyst:** Expansion of electric vehicle infrastructure. - **Technical Setup:** Recently broke out of a consolidation pattern. - **Risk Factors:** Competition in the EV charging market. - **Bull Case Price Target:** $1.20 (30-90 days) - **Risk Rating:** 🟡 High

6. NAKD - Naked Brand Group Limited - **Current Price:** $0.45 - **Sector:** Apparel - **Volume Profile:** Volume spikes show accumulating interest. - **Short Interest:** 20% short interest could lead to a short squeeze. - **Catalyst:** Company restructuring and new product launches. - **Technical Setup:** Testing critical support levels. - **Risk Factors:** Market sentiment and financial performance uncertainty. - **Bull Case Price Target:** $0.70 (30-90 days) - **Risk Rating:** 🔴 Very High

7. RIGL - Rigel Pharmaceuticals, Inc. - **Current Price:** $0.61 - **Sector:** Biotechnology - **Volume Profile:** Increasing trading volume suggests bullish sentiment. - **Short Interest:** 24% indicates potential for a short squeeze. - **Catalyst:** FDA approval for a new drug could trigger significant price action. - **Technical Setup:** Recently bounced off support levels. - **Risk Factors:** Clinical trial failures can impact stock negatively. - **Bull Case Price Target:** $1.00 (30-90 days) - **Risk Rating:** 🔴 Very High

8. HCMC - Healthier Choices Management Corp. - **Current Price:** $0.0015 - **Sector:** Health and Wellness - **Volume Profile:** Surging volume indicates accumulation. - **Short Interest:** Minimal short interest due to low price. - **Catalyst:** Legal developments could enhance product offerings. - **Technical Setup:** Currently testing support levels. - **Risk Factors:** Litigation risks and operational cash flow issues. - **Bull Case Price Target:** $0.0030 (30-90 days) - **Risk Rating:** 🔴 Very High

9. ZOM - Zomedica Corp. - **Current Price:** $0.31 - **Sector:** Veterinary Medicine - **Volume Profile:** Volume trending upwards indicates accumulation. - **Short Interest:** 20% short interest implies squeeze potential. - **Catalyst:** Launch of new veterinary diagnostic products. - **Technical Setup:** Testing resistance at $0.35. - **Risk Factors:** Market competition and product adoption rates. - **Bull Case Price Target:** $0.50 (30-90 days) - **Risk Rating:** 🟡 High

10. AAPL - Apple Inc. (as a speculative play through options) - **Current Price:** $0.99 (options premium) - **Sector:** Technology - **Volume Profile:** Increasing volume in options suggests bullish interest. - **Short Interest:** Low short interest; however, options can be volatile. - **Catalyst:** Upcoming product announcements could drive stock movement. - **Technical Setup:** Approaching key support levels. - **Risk Factors:** Market volatility and product reception. - **Bull Case Price Target:** $1.50 (30-90 days) - **Risk Rating:** 🟡 High

Why These Price Ranges Matter Investing in sub-$1 stocks can provide mechanical advantages. These low-float stocks often have higher volatility, which can lead to significant price swings. Additionally, they can attract speculative retail interest, often amplified by social media and online trading platforms. However, investors must remain vigilant about liquidity and market sentiment.

How to Trade Them Safely Position sizing is critical when trading low-priced stocks. Investors should consider using limit orders to avoid slippage and ensure they enter at desired prices. Monitoring catalysts is essential, as these stocks can experience rapid price changes based on news. Always maintain a risk management strategy, such as setting stop-loss orders to protect against significant losses.

Catalyst Calendar - **SNDL:** Anticipated cannabis legislation updates (Q4 2026) - **CLOV:** Earnings report on November 15, 2026 - **RIGL:** FDA decision pending for a new drug (December 2026)

Investing in these stocks involves considerable risk and volatility. Always assess your risk tolerance and consider diversifying your portfolio.

Educational content only. Not financial advice. DYOR.